Herbal and Antioxidant Derivatives

Herbal and Antioxidant Derivatives (HAD) is a specialized pharmaceutical manufacturing company based in Soual, France, operating as a joint venture between the German Schwabe Group and the French Ipsen Group. The company is primarily focused on the large-scale production and purification of standardized botanical extracts, specifically the Ginkgo biloba extract EGb 761. This extract is utilized globally in pharmaceutical products such as Tanakan and Tebonin for treating cognitive decline, tinnitus, and peripheral arterial diseases. HAD's facility in Soual is equipped with advanced technology for complex extraction processes, ensuring high levels of purity and standardization for its antioxidant-rich derivatives. The company plays a vital role in the supply chain for its parent organizations' neurology and vascular portfolios.